What does GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE do?

GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE is a specialist medical practice in Oudenaarde. Non-profit, started on 16 February 2004, 1 establishment.

What is the address of GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE?

The registered office of GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE is located at Minderbroedersstraat 3, 9700 Oudenaarde.

Is GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE still active?

Yes. According to the CBE (17 September 2026) GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE is active, legal situation “Normale toestand”, started on 16 February 2004.

Is GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE registered on Peppol?

Yes, GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE is registered on the Peppol network with ID 0208:0863456188.

What is the enterprise number of GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE?

The enterprise number of GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE is BE0863456188.

Who are the directors of GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE?

According to the 2025 annual accounts, the directors of GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE are: Geert BRANTEGEM, Mark REMERY, Sarah JEURISSEN, Steven SEGERS, Cedric ROBBRECHT, Thomas THUYSBAERT, Frank HATEM, Tom HENCKENS.

Is GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 16 February 2004; 5 annual accounts filed, latest fiscal year 2025; 10 directors known from the annual account.

How much profit did GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE make in 2025?

GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE recorded a loss after taxes of € 1,144,870 in financial year 2025.

What is the revenue of GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE?

In its most recent annual accounts (2025), GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE reported revenue of € 36,234,689.

How much does an employee at GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE earn?

The average wage cost per full-time employee at GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE was € 76,500 in 2025: staff costs of € 4.6 million for 59.8 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE have?

According to the 2025 annual accounts, GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE has 59.8 full-time equivalents (FTE).

GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE (Non-profit)

Q: When was GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE founded?

GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE was founded on 16 February 2004.

Dossier GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE, printed on 17 September 2026 from databakkes.be/en/0863456188/geneesheren-algemeen-ziekenhuis-oudenaarde. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE from Oudenaarde, company number BE0863456188, closed financial year 2025 with a result of € -1.1 million after tax. For that financial year GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE recorded revenue of € 36.2 million and equity of € 8.4 million. Compared with financial year 2024, the result moved from € 1.4 million to € -1.1 million. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 24, 2026.

What it is worth Healthy

€ 8.4 million

▼ 12% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -1.1 million

▼ still € 1.4 million profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 328,329

▼ 53% vs 2024

Cash and bank balances on the last day of the fiscal year.

People and assets in 2025

Full-time equivalents

59.8

▲ 4 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost Staff costs are payroll only. Director pay sits with services and miscellaneous goods: € 32.8 million in 2025, together with rent, insurance, accountants and other services. The accounts do not split that further.

€ 4.6 million

▲ 12% vs 2024

€ 76,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 5,997

▲ 54% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 1.4 million

▼ 28% vs 2024

€ 420,000 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 9.7 million

▲ 13% vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 108 days on average.

Taxes and wages

€ 739,011

▼ 5% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 30,628,993 Revenue 2022: € 30,628,993 First fiscal year in the series	€ 33,598,002 Revenue 2023: € 33,598,002 ▲ 10% vs 2022 (€ 30,628,993) Favourable step	€ 36,966,482 Revenue 2024: € 36,966,482 ▲ 10% vs 2023 (€ 33,598,002) Favourable step	€ 36,234,689 Revenue 2025: € 36,234,689 ▼ 2% vs 2024 (€ 36,966,482) Unfavourable step	▼ 2%
Profit after taxes	€ 1,116,191 Profit after taxes 2022: € 1,116,191 First fiscal year in the series	€ 1,095,052 Profit after taxes 2023: € 1,095,052 ▼ 2% vs 2022 (€ 1,116,191) Unfavourable step	€ 1,387,906 Profit after taxes 2024: € 1,387,906 ▲ 27% vs 2023 (€ 1,095,052) Favourable step	€ -1,144,870 Profit after taxes 2025: € -1,144,870 ▼ € 2.5 million vs 2024 (€ 1,387,906) Unfavourable step	▼ € 2.5 million
Equity	€ 7,099,799 Equity 2022: € 7,099,799 First fiscal year in the series	€ 8,194,851 Equity 2023: € 8,194,851 ▲ 15% vs 2022 (€ 7,099,799) Favourable step	€ 9,582,756 Equity 2024: € 9,582,756 ▲ 17% vs 2023 (€ 8,194,851) Favourable step	€ 8,437,886 Equity 2025: € 8,437,886 ▼ 12% vs 2024 (€ 9,582,756) Unfavourable step	▼ 12%
Total debts	€ 14,383,811 Total debts 2022: € 14,383,811 First fiscal year in the series	€ 14,142,381 Total debts 2023: € 14,142,381 ▼ 2% vs 2022 (€ 14,383,811) Favourable step	€ 11,822,560 Total debts 2024: € 11,822,560 ▼ 16% vs 2023 (€ 14,142,381) Favourable step	€ 12,246,136 Total debts 2025: € 12,246,136 ▲ 4% vs 2024 (€ 11,822,560) Unfavourable step	▲ 4%
Cash	€ 5,564,491 Cash 2022: € 5,564,491 First fiscal year in the series	€ 1,514,922 Cash 2023: € 1,514,922 ▼ 73% vs 2022 (€ 5,564,491) Unfavourable step	€ 702,258 Cash 2024: € 702,258 ▼ 54% vs 2023 (€ 1,514,922) Unfavourable step	€ 328,329 Cash 2025: € 328,329 ▼ 53% vs 2024 (€ 702,258) Unfavourable step	▼ 53%
Land & buildings	€ 60,000 Land & buildings 2022: € 60,000 First fiscal year in the series	€ 45,000 Land & buildings 2023: € 45,000 ▼ 25% vs 2022 (€ 60,000) Unchanged	€ 30,000 Land & buildings 2024: € 30,000 ▼ 33% vs 2023 (€ 45,000) Unchanged	€ 15,000 Land & buildings 2025: € 15,000 ▼ 50% vs 2024 (€ 30,000) Unchanged	▼ 50%
Retained profit	€ 6,209,799 Retained profit 2022: € 6,209,799 First fiscal year in the series	€ 7,304,851 Retained profit 2023: € 7,304,851 ▲ 18% vs 2022 (€ 6,209,799) Favourable step	€ 8,692,756 Retained profit 2024: € 8,692,756 ▲ 19% vs 2023 (€ 7,304,851) Favourable step	€ 7,547,886 Retained profit 2025: € 7,547,886 ▼ 13% vs 2024 (€ 8,692,756) Unfavourable step	▼ 13%
Bank debt	€ 3,149,762 Bank debt 2022: € 3,149,762 First fiscal year in the series	€ 2,558,333 Bank debt 2023: € 2,558,333 ▼ 19% vs 2022 (€ 3,149,762) Favourable step	€ 1,966,905 Bank debt 2024: € 1,966,905 ▼ 23% vs 2023 (€ 2,558,333) Favourable step	€ 1,418,333 Bank debt 2025: € 1,418,333 ▼ 28% vs 2024 (€ 1,966,905) Favourable step	▼ 28%
Balance sheet total	€ 21,583,610 Balance sheet total 2022: € 21,583,610 First fiscal year in the series	€ 22,437,232 Balance sheet total 2023: € 22,437,232 ▲ 4% vs 2022 (€ 21,583,610) Unchanged	€ 21,505,317 Balance sheet total 2024: € 21,505,317 ▼ 4% vs 2023 (€ 22,437,232) Unchanged	€ 20,784,022 Balance sheet total 2025: € 20,784,022 ▼ 3% vs 2024 (€ 21,505,317) Unchanged	▼ 3%
Employees (FTE)	40.8 Employees (FTE) 2022: 40.8 First fiscal year in the series	46.1 Employees (FTE) 2023: 46.1 ▲ 5.3 vs 2022 (40.8) Unchanged	55.8 Employees (FTE) 2024: 55.8 ▲ 9.7 vs 2023 (46.1) Unchanged	59.8 Employees (FTE) 2025: 59.8 ▲ 4 vs 2024 (55.8) Unchanged	▲ 4

Key figures of GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE?

What happened at GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2026 Mark REMERY stepped down as director. NBB
2026 Sarah JEURISSEN stepped down as director. NBB
2026 Steven SEGERS stepped down as director. NBB
2026 Cedric ROBBRECHT stepped down as director. NBB
2026 Thomas THUYSBAERT stepped down as director. NBB
2026 Frank HATEM stepped down as director. NBB
2026 Tom HENCKENS stepped down as director. NBB
2026 Philippe VAN BIERVLIET stepped down as director. NBB

In short

From € 1.1 million profit in 2022 to € 1.1 million loss in 2025.

Best year ever: 2024, with € 1.4 million profit.

Pays suppliers within 108 days on average.

Original PDFs at the National Bank ↗

A new publication or filing at GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE? We notify you, reason included.

Follow GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Geert BRANTEGEM

GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE

CREAT

Behind GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE is Geert BRANTEGEM. It owns CREAT itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Geert BRANTEGEM

Andere functie

Mark REMERY

Chairman of the board

since 2026 · until 2026

Sarah JEURISSEN

Director

Also active at: Dr. Sarah Jeurissen, Oncologie

since 2026 · until 2026

Steven SEGERS

Director

Also active at: DR. STEVEN SEGERS - ANESTHESIST

since 2026 · until 2026

Cedric ROBBRECHT

Director

Also active at: Dr. Cedric Robbrecht Orthopedie

since 2026 · until 2026

Thomas THUYSBAERT

Director

Also active at: Dr. Thomas Thuysbaert - Radioloog

since 2026 · until 2026

Frank HATEM

Vice-chairman of the board

Also active at: DR. FRANK HATEM-RADIOLOOG

since 2026 · until 2026

Tom HENCKENS

Director

since 2026 · until 2026

Philippe VAN BIERVLIET

Director

since 2026 · until 2026

Sophie VANHERPEN

Director

Also active at: Dokter Sophie Vanherpen

since 2026 · until 2026

Establishments

Establishment units

Physical locations of this company

Registered office

Minderbroedersstraat 3

9700 Oudenaarde

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.

All companies at this address →

Geneeskundige Kring Oudenaarde

ASSOCIATIE INTERNISTEN AZ OUDENAARDE VVZRL

Algemeen Ziekenhuis Oudenaarde

Geneesheren pneumologie AZ Oudenaarde

ASSOCIATIE MEDISCHE ONCOLOGIE OUDENAARDE

+1 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0863.456.188

VAT number

BE 0863.456.188

Registered office

Minderbroedersstraat 3, 9700 Oudenaarde

Names & denominations

GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE

Enterprise type

Rechtspersoon

Legal form

Non-profit association

Legal situation

Normale toestand

Start date

16 February 2004

Peppol

Active · Active since 13 Jan 2026

Activities · NACE

Activiteiten van medisch specialisten

Medische praktijken

View on CBE Public ↗ Annual accounts (NBB) ↗

GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE

Financials

What happened to GENEESHEREN ALGEMEEN ZIEKENHUIS OUDENAARDE?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions